Twin Peaks Wealth Advisors’s Bristol-Myers Squibb BMY Stock Holding History
Bought
Maintained
Sold
Other funds holding BMY
VCM
VPM
Twin Peaks Wealth Advisors's BMY Position: Q1 2026 in Review
Twin Peaks Wealth Advisors opened a new position in Bristol-Myers Squibb (BMY) in Q1 2026: 1,697 shares worth $103K. The stake represents 0.03% of the portfolio and ranks #287 among its holdings. This is a return to the name: Twin Peaks Wealth Advisors previously reported a position in BMY as recently as Q2 2025.
Twin Peaks Wealth Advisors first reported a position in BMY in Q2 2025 and has held it in 2 quarters since. 2,518 funds tracked by Wall St. Rank hold BMY as of Q1 2026.
- Twin Peaks Wealth Advisors held 1,697 shares of Bristol-Myers Squibb worth $103K as of Q1 2026.
- Bristol-Myers Squibb was a new Twin Peaks Wealth Advisors position in Q1 2026.
- Bristol-Myers Squibb made up 0.03% of Twin Peaks Wealth Advisors's portfolio in Q1 2026, its #287 holding.
- Twin Peaks Wealth Advisors first reported a position in Bristol-Myers Squibb in Q2 2025 and has held it in 2 quarters since.
- 2,518 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q1 2026.
Based on Twin Peaks Wealth Advisors's 13F filing for Q1 2026, filed 8 May 2026.